Windtree Historical Income Statement

WINT Stock

USD 1.64 0.06 3.53%

Historical analysis of Windtree Therapeutics income statement accounts such as Depreciation And Amortization of 89.6 K, Interest Expense of 54.6 K, Total Revenue of 0.0 or Other Operating Expenses of 29 M can show how well Windtree Therapeutics performed in making a profits. Evaluating Windtree Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Windtree Therapeutics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Windtree Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Windtree Therapeutics is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

About Windtree Income Statement Analysis

Windtree Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Windtree Therapeutics shareholders. The income statement also shows Windtree investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Windtree Therapeutics Income Statement Chart

At this time, Windtree Therapeutics' Other Operating Expenses is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 28.8 M in 2025, whereas Gross Profit is likely to drop (99 K) in 2025.

Other Operating Expenses Total Operating Expenses Selling General Administrative Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Windtree Therapeutics. It is also known as Windtree Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Windtree Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Windtree Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.At this time, Windtree Therapeutics' Other Operating Expenses is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 28.8 M in 2025, whereas Gross Profit is likely to drop (99 K) in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	53K	50K	57.5K	54.6K
Depreciation And Amortization	1.1M	82K	94.3K	89.6K

Interest Expense Depreciation And Amortization

Windtree Therapeutics income statement Correlations

	Depreciation And Amortization	Interest Expense	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Net Income From Continuing Ops	Non Operating Income Net Other	Interest Income	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		-0.06	-0.34	0.24	-0.38	-0.38	-0.36	0.06	0.25	-0.34	-0.19	-0.38	-0.13	0.65	0.12	-0.33	-0.09	0.3	-0.14	0.44	0.4
Interest Expense	-0.06		0.33	0.57	-0.22	-0.19	-0.19	-0.01	0.54	-0.33	0.13	-0.4	0.49	0.3	0.65	-0.37	-0.43	0.36	-0.58	-0.01	0.25
Gross Profit	-0.34	0.33		-0.06	0.38	0.39	0.39	0.45	-0.06	0.39	0.55	0.36	0.29	-0.22	0.17	0.41	0.27	-0.05	-0.53	-0.28	0.15
Other Operating Expenses	0.24	0.57	-0.06		-0.67	-0.68	-0.68	-0.14	1.0	-0.7	-0.07	-0.75	0.08	0.7	0.95	-0.64	-0.28	0.3	-0.35	0.0	0.08
Operating Income	-0.38	-0.22	0.38	-0.67		1.0	1.0	0.18	-0.68	0.97	0.73	0.95	0.47	-0.72	-0.57	0.91	0.2	-0.04	0.04	-0.32	-0.31
Ebit	-0.38	-0.19	0.39	-0.68	1.0		1.0	0.15	-0.68	0.96	0.72	0.94	0.5	-0.7	-0.57	0.9	0.2	-0.04	0.03	-0.29	-0.28
Ebitda	-0.36	-0.19	0.39	-0.68	1.0	1.0		0.16	-0.68	0.96	0.72	0.94	0.5	-0.69	-0.58	0.9	0.2	-0.03	0.02	-0.28	-0.27
Cost Of Revenue	0.06	-0.01	0.45	-0.14	0.18	0.15	0.16		-0.14	0.27	0.3	0.28	-0.2	-0.06	-0.03	0.37	0.39	0.1	-0.32	0.01	0.19
Total Operating Expenses	0.25	0.54	-0.06	1.0	-0.68	-0.68	-0.68	-0.14		-0.7	-0.07	-0.75	0.07	0.71	0.95	-0.64	-0.28	0.28	-0.34	0.0	0.08
Income Before Tax	-0.34	-0.33	0.39	-0.7	0.97	0.96	0.96	0.27	-0.7		0.74	0.99	0.35	-0.69	-0.61	0.95	0.42	-0.06	0.03	-0.27	-0.28
Total Other Income Expense Net	-0.19	0.13	0.55	-0.07	0.73	0.72	0.72	0.3	-0.07	0.74		0.67	0.61	-0.23	0.03	0.72	0.29	0.25	-0.4	-0.31	-0.08
Net Income	-0.38	-0.4	0.36	-0.75	0.95	0.94	0.94	0.28	-0.75	0.99	0.67		0.26	-0.71	-0.66	0.95	0.46	-0.1	0.09	-0.28	-0.29
Income Tax Expense	-0.13	0.49	0.29	0.08	0.47	0.5	0.5	-0.2	0.07	0.35	0.61	0.26		-0.2	0.18	0.29	-0.26	0.14	-0.25	-0.06	-0.08
Selling General Administrative	0.65	0.3	-0.22	0.7	-0.72	-0.7	-0.69	-0.06	0.71	-0.69	-0.23	-0.71	-0.2		0.56	-0.65	-0.09	0.32	-0.35	0.35	0.53
Research Development	0.12	0.65	0.17	0.95	-0.57	-0.57	-0.58	-0.03	0.95	-0.61	0.03	-0.66	0.18	0.56		-0.57	-0.29	0.3	-0.49	-0.02	0.07
Net Income From Continuing Ops	-0.33	-0.37	0.41	-0.64	0.91	0.9	0.9	0.37	-0.64	0.95	0.72	0.95	0.29	-0.65	-0.57		0.48	-0.25	0.16	-0.27	-0.26
Non Operating Income Net Other	-0.09	-0.43	0.27	-0.28	0.2	0.2	0.2	0.39	-0.28	0.42	0.29	0.46	-0.26	-0.09	-0.29	0.48		-0.22	0.01	0.0	0.01
Interest Income	0.3	0.36	-0.05	0.3	-0.04	-0.04	-0.03	0.1	0.28	-0.06	0.25	-0.1	0.14	0.32	0.3	-0.25	-0.22		-0.75	-0.01	0.23
Net Interest Income	-0.14	-0.58	-0.53	-0.35	0.04	0.03	0.02	-0.32	-0.34	0.03	-0.4	0.09	-0.25	-0.35	-0.49	0.16	0.01	-0.75		-0.03	-0.46
Reconciled Depreciation	0.44	-0.01	-0.28	0.0	-0.32	-0.29	-0.28	0.01	0.0	-0.27	-0.31	-0.28	-0.06	0.35	-0.02	-0.27	0.0	-0.01	-0.03		0.36
Selling And Marketing Expenses	0.4	0.25	0.15	0.08	-0.31	-0.28	-0.27	0.19	0.08	-0.28	-0.08	-0.29	-0.08	0.53	0.07	-0.26	0.01	0.23	-0.46	0.36

Click cells to compare fundamentals

Windtree Therapeutics Account Relationship Matchups

Windtree Therapeutics income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	638K	869K	1.1M	82K	94.3K	89.6K
Interest Expense	125K	114K	53K	50K	57.5K	54.6K
Gross Profit	(638K)	(869K)	(1.1M)	(82K)	(94.3K)	(99.0K)
Other Operating Expenses	30.3M	32.3M	21.9M	17.5M	20.2M	29.0M
Operating Income	(30.3M)	(77.3M)	(41.3M)	(17.5M)	(15.8M)	(16.6M)
Ebit	(32.4M)	(77.5M)	(40.5M)	(20.2M)	(18.2M)	(19.1M)
Ebitda	(31.8M)	(76.6M)	(39.5M)	(20.2M)	(18.1M)	(19.1M)
Cost Of Revenue	638K	869K	1.1M	82K	73.8K	70.1K
Total Operating Expenses	30.3M	32.3M	21.9M	17.5M	20.1M	28.8M
Income Before Tax	(32.6M)	(77.6M)	(40.6M)	(20.3M)	(18.3M)	(19.2M)
Total Other Income Expense Net	(2.2M)	(45.4M)	(19.1M)	(2.8M)	(2.5M)	(2.4M)
Net Income	(30.3M)	(67.6M)	(39.2M)	(20.3M)	(18.3M)	(19.2M)
Income Tax Expense	(2.3M)	(10.0M)	(1.4M)	(85.9K)	(77.3K)	(73.4K)
Selling General Administrative	14.9M	14.5M	10.8M	8.7K	10.0K	9.5K
Research Development	15.4M	17.8M	11.1M	8.3M	9.5M	18.7M
Net Income From Continuing Ops	(32.6M)	(67.6M)	(39.2M)	(20.3M)	(23.3M)	(24.5M)
Net Income Applicable To Common Shares	(34.8M)	(27.5M)	(32.6M)	(67.6M)	(60.9M)	(63.9M)
Interest Income	122K	91K	109K	325K	292.5K	406.5K
Net Interest Income	(3K)	(23K)	56K	275K	316.3K	332.1K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Windtree Historical Income Statement

About Windtree Income Statement Analysis

Windtree Therapeutics Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Windtree Therapeutics income statement Correlations

Windtree Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Windtree Therapeutics income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Windtree Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Depreciation And Amortization	Interest Expense
Total Revenue	Gross Profit
Other Operating Expenses	Operating Income
Ebit	Ebitda
Cost Of Revenue	Total Operating Expenses
Income Before Tax	Total Other Income Expense Net
Net Income	Income Tax Expense
Selling General Administrative	Research Development
Net Income From Continuing Ops	Non Operating Income Net Other
Net Income Applicable To Common Shares	Interest Income
Net Interest Income	Preferred Stock And Other Adjustments
Reconciled Depreciation	Tax Provision
Selling And Marketing Expenses

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Net Income	+ 0.99	Income Before Tax
Income Before Tax	+ 0.97	Operating Income

Net Interest Income	- 0.75	Interest Income
Net Income	- 0.75	Total Operating Expenses
Net Income	- 0.75	Other Operating Expenses
Selling General Administrative	- 0.72	Operating Income
Selling General Administrative	- 0.71	Net Income
Income Before Tax	- 0.7	Total Operating Expenses